FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Allergy topics
Autoimmune
Prophylactic
Ophthalmic
Autoimmune Disorder
Immune Disorder
Dermatitis
Staurosporin
Aspergillosis
Angioedema
Allergic Rhinitis
Food Allergy
Therapeutical
Bronchopulmonary
Staurosporine
Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Allergy patents



      
           
This page is updated frequently with new Allergy-related patent applications. Subscribe to the Allergy RSS feed to automatically get the update: related Allergy RSS feeds. RSS updates for this page: Allergy RSS RSS


Date/App# patent app List of recent Allergy-related patents
07/10/14
20140194586
 Method for treatment of synthetic rubber products, a system for treatment, the resulting rubber products, and use of a method to reduce type iv allergenicity of rubber products patent thumbnailMethod for treatment of synthetic rubber products, a system for treatment, the resulting rubber products, and use of a method to reduce type iv allergenicity of rubber products
The present invention relates to a method of reducing type iv rubber allergy of synthetic rubber latex products caused by chemical residues remaining after manufacture of the synthetic rubber products by reducing levels of chemical residues found for said products, said method comprising the steps of: subjecting said products to a wash in a strong alkaline solution to remove the chemical residues remaining after manufacture of the rubber latex products, and a system for reducing type iv allergenicity of synthetic rubber products caused by chemical residues remaining after manufacture of the synthetic rubber latex products by reducing residual levels of chemical residues found for said products, and a product, such as a glove, manufactured from synthetic rubber latex processed in accordance with the method and/or using the system. Further the invention relates to a use of a method of subjecting products to said wash and raising the temperature to at least 100c to remove the chemical residues remaining after manufacture of the synthetic rubber products..
07/10/14
20140193534
 Epicatechin for alleviating symptoms of allergy patent thumbnailEpicatechin for alleviating symptoms of allergy
The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products..
07/10/14
20140193450
 Peptide carrier fusion proteins as allergy vaccines patent thumbnailPeptide carrier fusion proteins as allergy vaccines
The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the n- and c-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.. .
07/10/14
20140193396
 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response patent thumbnailImmune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
The invention provides immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit tlr-mediated signaling in response to a tlr ligand or tlr agonist.
07/03/14
20140187892
 Device with integrated allergy testing patent thumbnailDevice with integrated allergy testing
The disclosure provides an allergy detection system for use during catheterization. The allergy detection system is incorporated into specialized syringes, connectors for use with standard syringes, or can be an independent test module designed for the sole purpose of allergy detection.
07/03/14
20140186403
 Peptide for vaccine patent thumbnailPeptide for vaccine
The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.. .
05/29/14
20140149114
Automatic decision support
Speech is transcribed to produce a transcript. At least some of the text in the transcript is encoded as data.
05/29/14
20140144555
 Bio-co-cr-mo alloy with ion elution suppressed by structure control, and process for producing same patent thumbnailBio-co-cr-mo alloy with ion elution suppressed by structure control, and process for producing same
This invention provides a technique for rendering bio-toxicity such as allergy toxicity derived from ni trace impurity, i.e., nickel toxicity, which is unavoidably present in a bio-co—cr—mo alloy or an ni-free stainless steel alloy unharmful, characterized in that an element selected from the group consisting of the group 4, 5 and 13 elements of the periodic table, particularly an element selected from the group consisting of the group 4 elements of the periodic table, is added to the alloy composition. The additive element is preferably an element selected from the group consisting of zirconium and titanium, more preferably zirconium..
05/22/14
20140142321
 Benzimidazole derivatives as pi3 kinase inhibitors patent thumbnailBenzimidazole derivatives as pi3 kinase inhibitors
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
05/22/14
20140141077
 Composition for use in treating and preventing inflammation related disorder patent thumbnailComposition for use in treating and preventing inflammation related disorder
The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (ha) or ha mixture, whereas the ha or the ha mixture as a delivery vehicle can be a formulation including at least two has having different average molecular weights. The composition has been demonstrated to be capable of reducing the therapeutic dose of a drug on the treatment and prevention of inflammation related disorders is acute inflammatory disease, chronic obstructed pulmonary disease, coeliac disease, conjunctivitis, otitis, allergic rhinitis, gingivitis, aphthous ulcer, bronchitis, gastroesophageal reflux disease (gerd), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (ibd), crohn's disease, irritable bowel syndrome (ibs), intestinal inflammation or allergy, urethritis, cystitis, vaginitis, proctitis, eosinophilic gastroenteritis, or rheumatoid arthritis..
05/15/14
20140135361
Anti-allergy benzocycloheptathiophene derivatives
A method for treating an allergic reaction, or allergy diseases or disorders includes administering a therapeutically effective composition comprising a compound of formula i or a pharmaceutically acceptable salt, solvate or prodrug thereof and a pharmaceutically acceptable carrier, vehicle or excipient to a subject in need thereof.. .
05/15/14
20140135290
Macrocyclic prodrug compounds useful as therapeutics
The present invention includes macrocyclic prodrug compounds, pharmaceutical compositions containing them. The present invention also includes use of these compounds in the treatment of various diseases including an autoimmune disease, an inflammatory disease, a neurological or neurodegenerative disease, cancer, a cardiovascular disease, allergy, asthma, a hormone-related disease, and tumors or symptoms resulting from neurofibromatosis..
05/15/14
20140134739
Method of genetically altering and producing allergy free cats
A transgenic cat with a phenotype characterized by the substantial absence of the major cat allergen, fel d i. The phenotype is conferred in the transgenic cat by disrupting the coding sequence of the target gene with a specialized construct.
05/08/14
20140127289
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.. .
05/08/14
20140124106
Silver-white copper alloy and method of producing silver-white copper alloy
Provided are a silver-white copper alloy which has superior mechanical properties such as hot workability, cold workability, or press property, color fastness, bactericidal and antibacterial properties, and ni allergy resistance; and a method of producing such a silver-white copper alloy. The silver-white copper alloy includes 51.0 mass % to 58.0 mass % of cu; 9.0 mass % to 12.5 mass % of ni; 0.0003 mass % to 0.010 mass % of c; 0.0005 mass % to 0.030 mass % of pb; and the balance of zn and inevitable impurities, in which a relationship of 65.5≦[cu]+1.2×[ni]≦70.0 is satisfied between a content of cu [cu] (mass %) and a content of ni [ni] (mass %).
05/01/14
20140121645
Methods and apparatus for the cvcs
The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (cvcs) via a valsalva maneuver. Because the cvcs is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply.
05/01/14
20140121356
Hypoallergenic mutant polypeptides based on fish parvalbumin
The present invention relates to non-naturally occurring polypeptides derived from fish allergens such as parvalbumin cyp c 1.01 from carp. The polypeptides display reduced allergenic activity and are useful as allergy vaccines for treatment of sensitized allergic patients and for prophylactic vaccination..
05/01/14
20140120563
Allergen testing platform for use with mobile electronic devices
An allergy testing system for use with a mobile electronic device having a camera includes a housing that can be attached to the mobile electronic device. First and second light sources within the housing are configured to illuminate, respectively, a test sample and a control sample.
05/01/14
20140120123
Fusion proteins for the treatment of allergic diseases
The present invention relates to a fusion protein comprising a first peptide and a second peptide linked together with a linker, wherein the first peptide is an allergen and the second peptide is a targeting unit and the second targeting unit peptide is a fgl-2 c-terminal peptide according to seq id no 1. Provided herein are also uses of said fusion protein as a vaccine for treating shrimp allergy, as well as a vaccine composition and methods of its production..
04/24/14
20140113964
Method of preventing and treating allergic airway diseases via intranasal gabexate mesilate
The present invention discloses a method of preventing and treating allergic airway diseases via intranasal gabexate mesilate, comprising administrating a pharmaceutically effective amount of a composition comprising a gabexate mesilate via nasal spray to prevent and treat allergy induced by a serine protease type allergen.. .
04/24/14
20140113915
Novel pyridopyrimidine derivatives and use thereof
The invention provides novel substituted pyridopyrimidines represented by formula i or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as inhibitors of the phosphoinositide 3′ oh kinase family (pi3k) for the treatment of inflammatory diseases, cancer, cardiovascular diseases, allergy, asthma and autoimmune disorders..
04/24/14
20140112822
Silver-white copper alloy and method of producing silver-white copper alloy
Provided are a silver-white copper alloy which has superior mechanical properties such as hot workability, cold workability, or press property, color fastness, bactericidal and antibacterial properties, and ni allergy resistance; and a method of producing such a silver-white copper alloy. The silver-white copper alloy includes 51.0 mass % to 58.0 mass % of cu; 9.0 mass % to 12.5 mass % of ni; 0.0003 mass % to 0.010 mass % of c; 0.0005 mass % to 0.030 mass % of pb; and the balance of zn and inevitable impurities, in which a relationship of 65.5≦[cu]+1.2×[ni]≦70.0 is satisfied between a content of cu [cu] (mass %) and a content of ni [ni] (mass %).
04/17/14
20140107398
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
04/17/14
20140107397
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
04/17/14
20140107102
Ocular allergy treatments
Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.. .
04/10/14
20140100234
Quinoline derivatives as pi3 kinase inhibitors
Invented is a method of inhibiting the activity/function of pi3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives..
04/10/14
20140099331
Zwitterionic immunomodulators for the teatment of asthma and allergy
Methods and products for treating and protecting against asthma and allergic conditions are provided. The methods and products are related to certain naturally occurring and synthetic zwitterionic polymers which are found to induce certain t regulatory (treg) cells and to exert immunosuppressive effects in vitro and in vivo..
04/03/14
20140093541
Treatment for peanut allergy
The present invention relates to oral immunotherapy for the desensitisation of patients who are hypersensitive to peanut allergen. The immunotherapy comprises increasing the oral dose daily dose of peanut protein administered to the patient at intervals of at least 2 weeks in a series of increments from an initial dose to a maximum dose, the series of dose increments including 2 mg, 5 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg and 800 mg; administering a daily oral dose of the maximum dose of peanut protein for at least 2 years and then administering a weekly oral dose of the maximum dose of peanut protein for at least 2 years..
04/03/14
20140093509
Screening method for the identification of agents capable of activating cd4+cd25+ regulatory t-cells through interactions with the hiv-1 gp120 binding site on cd4
The present invention relates specific activation of a regulatory t cell via a specific cd4 epitope and uses thereof, e.g. For the treatment of an autoimmune disease or an allergy or asthma or graft rejection or tolerance induction..
03/27/14
20140088172
Rnai-mediated inhibition of histamine receptor h1-related conditions
Rna interference is provided for inhibition of histamine receptor h1 mrna expression, in particular, for treating patients having an hrh1-related condition or at risk of developing an hrh1-related condition such as allergic conjunctivitis, ocular inflammation, dermatitis, rhinitis, asthma, or allergy.. .
03/20/14
20140081071
Methods and devices for treating primary headache
Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache.
03/20/14
20140080730
Method for predicting severity of allergic reaction
The present invention provides methods for determining a likelihood of a degree of allergic reaction or a severity thereof using a threshold value rather than the binding activity number between the immunoglobulin of the subject and a test composition comprising a marker protein moiety of the allergy inducing material. In one particular embodiment of the invention, methods are provided for determining a likelihood of a degree of allergic reaction severity of a subject to peanuts using a threshold value of binding between immunoglobulin e (ige) of the subject and ara h 2 moiety and ara h 6 moiety..
02/27/14
20140056933
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
The application is related to compositions and methods for the treatment of hypersensitivity, wherein the compositions comprise a particle packaged with immunostimulatory nucleic acids. The compositions of the invention are particularly useful in the treatment of atopic eczema, asthma and ige-mediated allergy (type i allergy), especially pollen allergy and house dust allergy..
02/27/14
20140056892
Vista-ig for treatment of autoimmune, allergic and inflammatory disorders
The present invention relates to a fusion proteins comprising regulatory t cell protein, vista (v-domain immunoglobulin suppressor of t cell activation (pd-l3) and an immunoglobulin protein (ig). The invention also provides the use of vista polypeptides, multimeric vista polypeptides, vista-conjugates (e.g., vista-ig), and vista antagonists for the treatment of autoimmune disease, allergy, and inflammatory conditions..
02/20/14
20140051677
Novel compound useful for the treatment of degenerative and inflammatory diseases
Novel pyrrazolopyridines according to formula i, able to inhibit jak are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prophylaxis and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergy, inflammatory conditions, autoimmune diseases, proliferative diseases, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of il6 or interferons.. .
02/20/14
20140050750
Vaccine peptide combinations against cat allergy
The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides. .
02/13/14
20140044744
Novel hypoallergens
The present invention provides mutant polypeptides useful as hypoallergens. More specifically the present invention provides mutant bet v 1 proteins and the use of such polypeptides as hypoallergens for desensitizing against birch pollen allergies.
02/06/14
20140038995
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by h4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis.. .
02/06/14
20140037792
Isolated microorganism strains lactobacillus plantarum mcc1 dsm 23881 and lactobacillus gasseri mcc2 dsm 23882 and their use
The present invention relates to new microorganism strains l. Plantarum mcc1 dsm 23881 and l.
02/06/14
20140037761
Method for preventing or treating an allergic disease using extract from illicium verum
The present invention provides a method for preventing or treating an allergic disease, comprising administering to a subject a composition comprising an extract from illicium verum as an active ingredient. The extract from illicium verum of the present invention reduces the secretion amount of increased histamine by compound 48/80 and the production amount of the increased allergenic cytokines (tnf-α, il-4 and il-8) by pma and a23187.
02/06/14
20140037686
Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
The present invention provides a probiotic, lactobacillus paracasei ncc 2461, i.e. St11, for use by administration to expectant females and/or lactating mothers, and to their progeny for the reduction or prevention of the development of allergic immune responses in progeny.
02/06/14
20140037663
Hypoallergen
The present invention provides mutant polypeptides useful as hypoallergens. More specifically the present invention provides mutant bet v 1 proteins and the use of such polypeptides as hypoallergens for desensitizing against birch pollen allergies.
02/06/14
20140037661
Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity
The present invention relates to the field of different wheat hypersensitivities, particularly with antigens and peptides for discrimination of different forms of these diseases. The invention relates to the identification of novel wheat allergens and the use thereof in therapy and diagnosis of celiac disease, dermatitis herpetiformis, and ige-mediated allergy.
02/06/14
20140037634
Regulatory t cell mediator proteins and uses thereof
In particular methods of using these proteins and compounds, preferably antibodies, which bind or modulate (agonize or antagonize) the activity of these proteins, as immune modulators and for the treatment of cancer, autoimmune disease, allergy, infection and inflammatory conditions, e.g. Multiple sclerosis is disclosed.
02/06/14
20140037603
Nutritional compositions including branched chain fatty acids for improving gut barrier function
Nutritional compositions for improving, treating and/or preventing various medical conditions and methods of using same are provided. Such medical conditions include infection, sepsis, malabsorption, allergy, inflammatory bowel disease, and diarrhea among others.
01/30/14
20140030376
Gluten-free ready-to-eat food composition
A gluten free, ready-to-eat food product is provided comprising millet and a flavoring. In some embodiments, the gluten-free food product may also be dairy-free and/or allergen free.
01/30/14
20140030218
Treatment and screening
A method of treating a patient having an autoimmune disease or a th1 polarising infection or a condition associated with inflammation other than asthma or allergy, the method comprising administering to the patient a therapeutically effective amount of an inhibitor of interferon regulatory factor 5 (irf5).. .
01/23/14
20140023669
Use of a hypoallergenic cereal composition for inducing specific oral tolerance
A partial hydrolysate of cereal protein for use in inducing specific oral tolerance in a young mammal with allergy to said cereal protein, wherein the hydrolysate has a degree of hydrolysis between 9 and 18%, is disclosed.. .
01/23/14
20140023614
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
The present invention relates to substituted fused tricyclic compounds of formula (i) or (ia), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, co-crystals, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by jak activity. The compounds of the present invention are useful in the treatment, prevention or suppression of diseases and disorders mediated by jak activity.
01/16/14
20140018908
Gene delivery stent using titanium oxide thin film coating, and method for fabricating same
The present invention relates to a gene delivery stent using titanium oxide thin film coating and a method for fabricating the gene delivery stent. The gene delivery stent according to the present invention may be loaded with a drug having anti-inflammatory and anti-thrombotic effects and simultaneously deliver a gene capable of inhibiting proliferation of vascular smooth muscle cells.
01/16/14
20140018534
Benzimidazole derivatives as pi3 kinase inhibitors
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kβ, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries.
01/16/14
20140018408
Oligonucleotides for treating inflammation and neoplastic cell proliferation
There is provided oligonucleotides directed against the ccr3 receptor and the common beta sub-unit of il-3, il-5 and gmcsf receptors. The oligonucleotides are useful to inhibit general inflammation, including inflammation associated with asthma, copd, allergy, cystic fibrosis (cf), hypereosinophilia and neoplastic cell proliferation such as cancer..
01/09/14
20140010849
Peanut allergy treatment
The present invention provides compositions, systems, and methods for preventing and treating allergic reactions to peanut exposure. In certain embodiments, the present invention employs fusion proteins comprising a peanut allergen (or allergenic portion thereof), such as ara h2, and an fc protein (e.g., fcγ1 protein), or functional portion thereof..
01/02/14
20140004100
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
The invention provides novel immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit or suppress tlr-mediated signaling in response to a tlr ligand or tlr agonist.
12/26/13
20130346074
Verification of extracted data
Facts are extracted from speech and recorded in a document using codings. Each coding represents an extracted fact and includes a code and a datum.
12/26/13
20130345209
Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
The present invention relates to the compound according to formula i, and to its use in medicine, in particular in the treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of il6 or interferons. In particular, the compound inhibits jak a family of tyrosine kinases, and more particularly jak1.
12/26/13
20130344042
Dietary management of celiac disease and food allergy
The present disclosure provides compositions and methods for dietary management of celiac disease and food allergy in a subject, such as a formula-fed infant, via enteral administration of an effective amount of at least one hydrolyzed protein and lactobacillus rhamnosus gg (lgg). The inventive nutritional compositions may contain a hydrolyzed protein component, a lipid component, a carbohydrate component, a vitamin component, a mineral component, and a prebiotic component in addition to a probiotic component, which comprises an effective amount of lgg..
12/19/13
20130336976
Human immune therapies using a cd27 agonist alone or in combination with other immune modulators
Methods of inducing t cell proliferation and expansion in vivo for treating conditions wherein antigen-specific t cell immune response are therapeutically desirable such as cancer, infection, inflammation, allergy and autoimmunity and for enhancing the efficacy of vaccines are provided. These methods comprise the administration of at least one cd27 agonist, preferably an agonistic cd27 antibody, alone or in association with another moiety such as immune stimulant or immune modulator such as an anti-cd40, ox-40, 4-1bb, or ctla-4 antibody or an agent that depletes regulatory cells, or a cytokine.
12/12/13
20130331418
Methods for preventing flea allergy dermatitis in companion animals
Methods for reducing the incidence of flea allergy dermatitis (fad) in a companion animal are disclosed, the methods directed to inhibiting blood feeding by ectoparasites on a companion animal. The methods of the present invention involve administering a pesticide composition comprising cyphenothrin to a companion animal, specifically dogs and cats, in doses and proportions which are parasiticidally effective against a variety of ectoparasites, and in formulations which are convenient for topical application to the animal's skin, preferably localized over a small surface area.
11/28/13
20130316026
Xylitol-based anti-mucosal compositions and related methods and compositions
Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy medication or another anti-mucosal composition. In some embodiments, a nasal solution for alleviating an allergy condition may comprise an anti-mucosal composition in an amount effective for treating an allergy condition and at least one of xylitol and xylose in an amount effective for reducing nasal dryness caused by the anti-mucosal composition..
11/21/13
20130309270
Vaccines comprising bisphosphonate and methods of use thereof
The present invention demonstrates that bisphosphonates have an intrinsic adjuvant activity and directly stimulate b cell antibody secretion. Accordingly, the present invention provides vaccines comprising a bisphosphonate, methods for stimulating an immune response, enhancing the immunogenicicty of an immunogen, and methods of treating an infection, an autoimmune disease, an allergy, and/or a cancer using the same..
11/21/13
20130309261
Hypoallergenic polypeptides for the treatment of house dust mite allergy
The present invention relates to a polypeptide comprising the amino acid sequence as shown in seq id no:9 or 7. The invention further pertains to nucleic acids encoding the polypeptide, pharmaceutical compositions and vaccines..
11/14/13
20130304184
Nickel-free stainless steel stent
A nickel-free stainless steel stent using a stainless steel which does not substantially contain ni in the stainless steel, has a metal allergy onset-preventing effect, and is excellent in terms of precision workability, strength, and ductility, is provided. The nickel-free stainless steel stent is characterized by using a stainless steel containing, as a chemical composition, from 15 to 30% by mass of cr, from 0.97 to 2% by mass of mo, and from 0.5 to 1% by mass of n, with the remainder being fe, and optionally containing inevitable impurities..
11/07/13
20130295200
Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
The present invention provides a method of treating or inhibiting at least one of allergic asthma, allergic rhinitis and atopic dermatitis, or of reducing, inhibiting or treating allergy like symptoms. The methods use compositions comprising chlorite, chloride, chlorate and/or sulfate ions..
11/07/13
20130295146
Composition for improving membrane composition and functioning of cells
The health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery..
11/07/13
20130295123
Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
The present invention relates to compositions for preventing or treating allergy to ragweed by tolerisation. The compositions are based on combinations of peptide fragments derived from the major allergen in ragweed pollen, amb a 1.


Popular terms: [SEARCH]

Allergy topics: Autoimmune, Prophylactic, Ophthalmic, Autoimmune Disorder, Immune Disorder, Dermatitis, Staurosporin, Aspergillosis, Angioedema, Allergic Rhinitis, Food Allergy, Therapeutical, Bronchopulmonary, Staurosporine, Sudden Infant Death

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Allergy for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Allergy with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2928

3085

2 - 1 - 71